Raison sociale: RARE THYROID THERAPEUTICS INTERNATIONAL AB
Nom international: Rare Thyroid Therapeutics International AB
Marque / Nom commercial: Egetis Therapeutics
Pays d'enregistrement: Sweden
Description:
Rare Thyroid Therapeutics International AB is a subsidiary of Egetis Therapeutics, a Swedish pharmaceutical company developing and commercialising treatments for rare diseases, in particular MCT8 deficiency.
Laissez votre note & commentaire